世界の医薬品添加物市場：糖質、オレオケミカル、石油化学品、ポリマーなど...市場調査レポートについてご紹介

1 Introduction (Page No. – 22)
1.1 Objectives Of The Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size Estimation
1.5.2 Market Crackdown & Data Triangulation
1.5.3 Market Share Estimation
1.5.4 Key Data Points From Secondary Sources
1.5.5 Key Data Points From Primary Sources

2 Executive Summary (Page No. – 31)

3 Premium Insights (Page No. – 35)
3.1 Need Of High Quality Excipients Driving Regulatory Transition
3.2 Growing Need Of New Excipients And Emergence Of Co-Processed Excipients
3.3 Future Of Excipients For Direct Compression
3.4 High Growth In Emerging Markets In Apac And Latin America
3.5 Fillers & Diluents To Remain The Largest Market By Functionality

4 Market Overview (Page No. – 45)
4.1 Introduction
4.2 Market Segmentation
4.3 Market Dynamics
4.3.1 Key Market Drivers
4.3.1.1 Growth Of The Global Pharmaceuticals Market Backed By Functional Excipients
4.3.1.2 Patent Cliff Driving The Growth Of Excipients In The Generics Market
4.3.1.3 Emergence Of New Excipients For The Pharmaceutical Industry
4.3.2 Key Challenges
4.3.2.1 Quality Concerns Demand Greater Transparency In Supply Chain
4.3.2.2 Declining R&D Investment Poses Long-Term Growth Barrier For The Market
4.3.2.3 Increased Regulatory Requirements Leading To Shortage Of U.S. FDA-Approved Manufacturing Sites
4.3.3 Key Market Opportunities
4.3.3.1 Shifting Focus Of Pharma Manufacturing To Emerging Countries
4.3.3.2 Multi-Functionality Excipients Are Proving To Be Emerging Areas Of New Product Developments
4.3.4 Key Market Trends
4.3.4.1 A New International Gmp & Gdp Certification For Pharmaceutical Excipients In North America And Europe (Excipact)
4.3.4.2 Increased Consolidation Based On Product Portfolio Improvement
4.4 Global Market Share Analysis
4.5 Market Share Analysis: North America
4.6 Market Share Analysis: Europe
4.7 Market Share Analysis: Apac
4.8 Value Chain Analysis

5 Global Pharmaceutical Excipients Market, By Product (Page No. – 63)
5.1 Introduction
5.2 Inorganic Chemicals
5.2.1 Calcium Phosphates
5.2.2 Calcium Carbonate
5.2.3 Calcium Sulfate
5.2.4 Halites
5.2.5 Metallic Oxides
5.3 Organic Chemicals
5.3.1 Carbohydrates
5.3.1.1 Sugars
5.3.1.1.1 Actual Sugars
5.3.1.1.1.1 Lactose
5.3.1.1.1.2 Sucrose
5.3.1.1.1.3 Dextrose (Glucose)
5.3.1.1.2 Sugar Alcohols
5.3.1.1.2.1 Sorbitol
5.3.1.1.2.2 Mannitol
5.3.1.1.2.3 Other Sugar Alcohols
5.3.1.1.3 Artificial Sweeteners
5.3.1.2 Starch
5.3.1.2.1 Modified Starch
5.3.1.2.2 Dried Starch
5.3.1.2.3 Converted Starch
5.3.1.3 Cellulose
5.3.1.3.1 Cellulose Ethers
5.3.1.3.2 Cellulose Esters
5.3.1.3.3 CMC And Croscarmellose Sodium
5.3.1.3.4 Microcrystalline Cellulose
5.3.2 Petrochemicals
5.3.2.1 Glycols
5.3.2.1.1 Polyethylene Glycol
5.3.2.1.2 Propylene Glycol
5.3.2.2 Povidones
5.3.2.3 Mineral Hydrocarbons
5.3.2.3.1 Petrolatum
5.3.2.3.2 Mineral Waxes
5.3.2.3.3 Mineral Oils
5.3.2.4 Acrylic Polymers
5.3.2.5 Other Petrochemical Excipients
5.3.3 Oleochemicals
5.3.3.1 Fatty Alcohols
5.3.3.2 Mineral Stearates
5.3.3.3 Glycerin
5.3.3.4 Other Oleochemical Excipients
5.3.4 Proteins

6 Global Pharmaceutical Excipients Market, By Functionality (Page No. – 122)
6.1 Introduction
6.2 Fillers & Diluents
6.3 Binders
6.4 Suspension & Viscosity Agents
6.5 Coatings
6.6 Flavoring Agents
6.7 Disintegrants
6.8 Colorants
6.9 Lubricants & Glidants
6.10 Preservatives

7 Geographic Analysis (Page No. – 144)
7.1 Introduction
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 France
7.3.3 U.K.
7.4 Asia-Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.5 Rest Of The World
7.5.1 Brazil

8 Competitive Landscape (Page No. – 199)
8.1 Introduction
8.1.1 New Product Launch
8.1.2 Mergers And Acquisitions
8.1.3 Agreements, Partnerships, Collaborations & Joint Ventures
8.1.4 Expansion
8.1.5 Other Developments
9 Company Profiles (Overview, Key Financials, Product Portfolio, Growth Strategy, & Developments)* (Page No. – 209)
9.1 Ashland Inc.
9.2 Basf Se
9.3 The Dow Chemical Company
9.4 Fmc Corporation
9.5 Associated British Foods Plc
9.6 Roquette
9.7 Evonik Industries Ag
9.8 Archer Daniels Midland Company
9.9 Lubrizol Corporation
9.10 Croda International Plc
9.11 Dfe Pharma
9.12 J. Rettenmaier & Söhne Gmbh & Co. Kg
9.13 Meggle Ag
9.14 Colorcon, Inc.
9.15 Avantor Performance Materials, Inc.
*Details On Key Financials, Product Portfolio, Growth Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies.